Hemab Therapeutics Holdings, Inc. Stock Performance
as on September 19, 2026 at 5:08 am IST
Day's Low
Day's High
$40.97$42.12
1.42%
Downside
1.35%
Upside
52 Week's Low
52 Week's High
100.00%
Downside
-100.00%
Upside
Hemab Therapeutics Holdings, Inc. share price movements today
- Previous Close
- $41.22
- Open
- $41.79
- Volume
- 189.9K
- Market Cap
- $1.9B
- Day's Low - High
- $40.97 - $42.12
Hemab Therapeutics Holdings, Inc. Historical Returns
- 1 Month Return
- -21.4 %
- 3 Month Return
- + 40.97 %
- 1 Year Return
- 0 %
- 3 Year Return
- 0 %
- 5 Year Return
- 0 %
Hemab Therapeutics Holdings, Inc. Stock Fundamentals & Key Indicators
Check Hemab Therapeutics Holdings, Inc. market cap, PE, PB, PEG ratios, dividend yield, and other key fundamental indicators.
Market Cap
$1.9B
EPS (TTM)
-1.31
Dividend Yield
0.00%
PE Ratio (TTM)
-31.47
Industry PE ratio
-6.87
PEG Ratio
-0.31465648854961825
Return On Equity TTM
-36.64%
Hemab Therapeutics Holdings, Inc. Stock Valuation
Track how Hemab Therapeutics Holdings, Inc. P/E has moved over time to understand its valuation trends.
Hemab Therapeutics Holdings, Inc. in the last 1 year
Lowest (-14.59x)
December 31, 2025
Today (-14.59x)
December 31, 2025
Industry (-6.87x)
December 31, 2025
Highest (-14.59x)
December 31, 2025
Today’s Price to Earnings Ratio: -14.59x
Hemab Therapeutics Holdings, Inc. vs Peer Comparison
Compare market cap, revenue, PE, and other key metrics of Hemab Therapeutics Holdings, Inc. with its industry peers.
Company | Analyst View | Market Cap | 5 Years Return % | PE Ratio | Profit Margin % | Dividend Yield % |
|---|---|---|---|---|---|---|
| StrongBuy | $1.9B | NA | -31.47 | 0.00% | 0.00% | |
| BUY | $63.1B | -63.24% | -19.81 | -12.57% | 0.00% | |
| BUY | $130.1B | 174.21% | 29.81 | 86.04% | 0.00% | |
| BUY | $79.7B | 21.1% | 18.48 | 84.86% | 0.48% |
Analyst Recommendation on Hemab Therapeutics Holdings, Inc. Stock
Based on 4 analysts
100.00%
Buy
0.00%
Hold
0.00%
Sell
Based on 4 analysts, 100% of analysts recommend a 'BUY' rating for Hemab Therapeutics Holdings, Inc.. Average target price of $54.25
Indian Investors' Interest in Hemab Therapeutics Holdings, Inc. Stock
Search interest for Hemab Therapeutics Holdings, Inc. Stock has decreased by -62% in the last 30 days, reflecting a downward trend in search activity.
Time period: to
Hemab Therapeutics Holdings, Inc. Quarterly Profit & Loss
All numbers in Millions USD
Hemab Therapeutics Holdings, Inc. Annual Profit & Loss
All numbers in Millions USD
Hemab Therapeutics Holdings, Inc. Quarterly Cash Flow
All numbers in Millions USD
Hemab Therapeutics Holdings, Inc. Annual Cash Flow
All numbers in Millions USD
Hemab Therapeutics Holdings, Inc. News & Key Events
Today's Timeline - 26 May
Tue, 07:38 PM
-Goldman Sachs initiates coverage of Hemab Therapeutics with a Buy rating and $36 price target, citing strong upside potential.
Insights on Hemab Therapeutics Holdings, Inc.
Insights help you understand the recent movement of the company's critical parameters, giving you an overall view of the company.
NEGATIVE IMPACTPrice Dip
In the last 1 month, COAG stock has moved down by -21.4%
About Hemab Therapeutics Holdings, Inc.
| Organisation | Hemab Therapeutics Holdings, Inc. |
| Headquarters | 101 Main Street, Cambridge, MA, United States, 02142 |
| Industry | Biotechnology |
| CEO | Dr. Benny Sorensen M.D., Ph.D. |
| E-voting on shares | Click here to vote |
Key Management of Hemab Therapeutics Holdings, Inc.
Name | Title |
|---|---|
Ms. Karen Weisbach | Chief People & Culture Officer |
Ms. Cecile Bonvoisin M.Sc. | Senior Vice President of CMC & Manufacturing |
Ms. Tara O'Meara | Senior Vice President of Development Operations |
Dr. Benny Sorensen M.D., Ph.D. | President, CEO & Director |
Mr. Mads Nikolaj Behrndt-Eriksen M.Sc. | CFO & GM |
Dr. Catherine Eilleen Madigan M.D. | Chief Medical Officer |
Dr. Ananthram Sreenivasa Murthy M.Sc., Ph.D. | Chief Operating Officer |
FAQs
What is Hemab Therapeutics Holdings, Inc. share price today?
Hemab Therapeutics Holdings, Inc. share price today is $41.56 as on . Hemab Therapeutics Holdings, Inc. share today touched a day high of $42.12 and a low of $40.97.
What is the 52 week high and 52 week low for Hemab Therapeutics Holdings, Inc. share?
Hemab Therapeutics Holdings, Inc. share touched a 52 week high of $0.00 on and a 52 week low of $0.00 on . Hemab Therapeutics Holdings, Inc. stock price today i.e. is trending at $41.56,which is -Infinity% down from its 52 week high and Infinity% up from its 52 week low.
What is Hemab Therapeutics Holdings, Inc.'s market capitalisation today?
Hemab Therapeutics Holdings, Inc. market capitalisation is $0.00T as on .
How to invest in Hemab Therapeutics Holdings, Inc. Stock (COAG) from India?
- Step 1: Open a free US stocks account on INDmoney App and transfer your Rupees into Dollars to your INDmoney US stocks account. For a step by step instruction, check How to Transfer Money to Your US Stocks Account .
- Step 2: Search for Hemab Therapeutics Holdings, Inc. on INDmoney app. Click on Buy button. You can invest as low as $1.5 in Hemab Therapeutics Holdings, Inc. Shares that will get you 0.0361 shares as per Hemab Therapeutics Holdings, Inc. share price of $41.56 per share as on September 18, 2026 at 11:38 pm IST.
What is the minimum amount required to buy Hemab Therapeutics Holdings, Inc. Stock (COAG) from India?
Indian investors can start investing in Hemab Therapeutics Holdings, Inc. (COAG) shares with as little as ₹95.8725 or $1 (as of ) using the INDmoney app.
For example: If you want to invest $10 or ₹958.73 in Hemab Therapeutics Holdings, Inc. stock (as per the Rupee-Dollar exchange rate as on ).
Based on Hemab Therapeutics Holdings, Inc. share’s latest price of $41.56 as on September 18, 2026 at 11:38 pm IST, you will get 0.2406 shares of Hemab Therapeutics Holdings, Inc.. Learn more about
fractional shares .